Completed PHASE1 INTERVENTIONAL NCT00872846

Balance System Study in Type 2 Diabetic Patients

Evaluation of the BALANCE System in Type 2 Diabetic Patients

Sponsor: Beta-Stim Ltd.

Interventions BALANCE System intestinal electrical stimulator

Updated 5 times since 2017 Last updated: Jan 23, 2012 Started: Feb 28, 2009 Primary completion: Jan 31, 2012 Completion: Jan 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00872846, this PHASE1 trial focuses on Obesity and Type 2 Diabetes and remains completed. Sponsored by Beta-Stim Ltd., it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beta-Stim Ltd.
Meditrial Europe Ltd.

Data source: Beta-Stim Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany